DIA Offers Clinical Safety and Pharmacovigilance Certification

Wednesday, December 30, 2009 07:21 AM

The Drug Information Association (DIA) recently launched its Clinical Safety and Pharmacovigilance Certificate Program—the organization’s third certificate program for clinical research professionals.

The new program focuses on topics related to pre- and postmarketing clinical safety and pharmacovigilance, risk-management strategies, safety inspections, signal detection and data mining, medical approaches in diagnosis and management of adverse drug reactions and drug safety surveillance and epidemiology.

Enrollment in the program is free, and fees for each course vary based on length.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs